RCM
PRAX icon

RA Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

RA Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120M Hold
373,787
– – 1.28% 18
2025
Q4 		$110M Buy
+373,787
New +$69.6M 1.13% 21
2025
Q1 		– Sell
-761,955
Closed -$58.6M – 94
2024
Q4 		$58.6M Hold
761,955
– – 0.78% 27
2024
Q3 		$43.8M Sell
761,955
-473,644
-38% -$25.6M 0.51% 41
2024
Q2 		$51.1M Buy
1,235,599
+407,219
+49% +$19.2M 0.68% 37
2024
Q1 		$50.5M Buy
+828,380
New +$37.2M 0.64% 41

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

RA Capital Management's PRAX Position: Q1 2026 in Review

RA Capital Management held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 373,787 shares worth $120M. The position accounts for 1.28% of the portfolio, ranked #18.

RA Capital Management first reported a position in PRAX in Q1 2024 and has held it in 6 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • RA Capital Management held 373,787 shares of Praxis Precision Medicines worth $120M as of Q1 2026.
  • RA Capital Management left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 1.28% of RA Capital Management's portfolio in Q1 2026, its #18 holding.
  • RA Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 6 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on RA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.